GSC
DXCM icon

Grey Street Capital’s DexCom DXCM Stock Holding History

Grey Street Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$243K Buy
+1,754
New +$220K 0.03% 434

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Grey Street Capital's DXCM Position: Q1 2024 in Review

Grey Street Capital opened a new position in DexCom (DXCM) in Q1 2024: 1,754 shares worth $243K. The stake represents 0.03% of the portfolio and ranks #434 among its holdings.

1,034 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Grey Street Capital held 1,754 shares of DexCom worth $243K as of Q1 2024.
  • DexCom was a new Grey Street Capital position in Q1 2024.
  • DexCom made up 0.03% of Grey Street Capital's portfolio in Q1 2024, its #434 holding.
  • 1,034 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.